APA (7th ed.) Citation

A, S., LB, M., J, L., R, M., & S, W. (2026). Cell-cycle targeted cancer therapy: Clinical advances, biological gaps, and the emergence of selective CDK4 inhibitors. Journal of hematology & oncology, 19(1), . https://doi.org/10.1186/s13045-026-01794-7

Chicago Style (17th ed.) Citation

A, Safaroghli-Azar, Mekonnen LB, Lenjisa J, Milne R, and Wang S. "Cell-cycle Targeted Cancer Therapy: Clinical Advances, Biological Gaps, and the Emergence of Selective CDK4 Inhibitors." Journal of Hematology & Oncology 19, no. 1 (2026). https://doi.org/10.1186/s13045-026-01794-7.

MLA (9th ed.) Citation

A, Safaroghli-Azar, et al. "Cell-cycle Targeted Cancer Therapy: Clinical Advances, Biological Gaps, and the Emergence of Selective CDK4 Inhibitors." Journal of Hematology & Oncology, vol. 19, no. 1, 2026, https://doi.org/10.1186/s13045-026-01794-7.